LobbyingWeill Cornell Medicine lobbying by quarter
Weill Cornell Medicine's latest lobbying report covers Q2 2026, at $50K. The four quarters Q3 2025–Q2 2026 total $140K. Its first report covers Q2 2025; the issues it reports most are Health Issues.
Weill Cornell Medicine
- Latest quarter
- $50K
- Q2 2026 · 1 reports
- Last 12 months
- $140K
- Last 4 quarters
- vs last quarter
- 0.0%
- Q2 2026 against the quarter before
- First report
- Q2 2025
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q2 2025 | $20K | 1 |
| Q3 2025 | $20K | 1 |
| Q4 2025 | $20K | 1 |
| Q1 2026 | $50K | 1 |
| Q2 2026 | $50K | 1 |
Policy issues the reports name
- Health issues5 reports
A report that names several issues counts once for each.
Who was lobbied
- Office of Administration5 reports
Firms it paid
| Firm | ||
|---|---|---|
| Mercury Public Affairs | $160K | 5 quarters |
Former officials lobbying for it
No lobbyist with a covered position.
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/16for Q2 | Mercury Public Affairs | $50K |
| 04/16for Q1 | Mercury Public Affairs | $50K |
| 01/15for Q4 2025 | Mercury Public Affairs | $20K |
| 25/10/20for Q3 2025 | Mercury Public Affairs | $20K |
| 25/07/14for Q2 2025 | Mercury Public Affairs | $20K |
| 25/06/09for Q2 2025 | Mercury Public Affairs | Under $5,000 |